CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...
Phase 1, Phase 2
Tampa, Florida, United States and 7 other locations
This prospective, multicenter, 1:1 randomized, controlled trial is designed to evaluate the safety and effectiveness of the Breast Cancer...
Tampa, Florida, United States and 25 other locations
A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in participants with advanced Breast Cancer for whom Standard of C...
Phase 1
Sarasota, Florida, United States and 3 other locations
The purpose of this study is to assess safety and tolerability of AZD2014 when given in combination with Fulvestrant
Phase 1
Sarasota, Florida, United States and 4 other locations
to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...
Phase 2
St Petersburg, Florida, United States and 10 other locations
as a possible adjuvant treatment for Stage II or III Triple Negative Breast Cancer. This research study is studying the safety, tol...
Phase 1
Tampa, Florida, United States and 4 other locations
This study is to find out if administration of stereotactic radiosurgery (SRS) given after Nivolumab will improve overall response rate/anti-tumor...
Phase 1
Tampa, Florida, United States
and efficacy of the oral chemotherapy capecitabine in combination with cemiplimab in patients with hormone-receptor-positive (HR+) metastatic breast...
Phase 1
Tampa, Florida, United States
growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-dependent kinase targeting...
Phase 2
Clearwater, Florida, United States and 33 other locations
(a modified herpes simplex 1 virus that can specifically destroy cancer cells while leaving normal cells alone) injected directly into the t ...
Phase 1, Phase 2
Tampa, Florida, United States
Clinical trials
Research sites
Resources
Legal